IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 40.30B
Enterprise value 41.51B
Trailing P/E 58.43
Forward P/E 51.55
PEG ratio (5-yr expected) 4.54
Price/sales (ttm)11.92
Price/book (mrq)47.92
Enterprise value/revenue 12.10
Enterprise value/EBITDA 39.69

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 326.13%
S&P500 52-week change 32.54%
52-week high 3515.79
52-week low 3317.06
50-day moving average 3482.83
200-day moving average 3428.74

Share statistics

Avg vol (3-month) 3381.15k
Avg vol (10-day) 3404.45k
Shares outstanding 582.9M
Implied shares outstanding 6N/A
Float 882.16M
% held by insiders 10.93%
% held by institutions 192.80%
Shares short (14 May 2023) 42.21M
Short ratio (14 May 2023) 46.22
Short % of float (14 May 2023) 43.00%
Short % of shares outstanding (14 May 2023) 42.66%
Shares short (prior month 13 Apr 2023) 41.87M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 20.38%
Operating margin (ttm)27.13%

Management effectiveness

Return on assets (ttm)21.54%
Return on equity (ttm)94.43%

Income statement

Revenue (ttm)3.43B
Revenue per share (ttm)41.20
Quarterly revenue growth (yoy)7.60%
Gross profit (ttm)2B
Net income avi to common (ttm)699.18M
Diluted EPS (ttm)8.49
Quarterly earnings growth (yoy)10.40%

Balance sheet

Total cash (mrq)111.37M
Total cash per share (mrq)1.34
Total debt (mrq)1.32B
Total debt/equity (mrq)156.96
Current ratio (mrq)1.08
Book value per share (mrq)10.13

Cash flow statement

Operating cash flow (ttm)612.19M
Levered free cash flow (ttm)398.99M